ES2089497T3 - Derivados de 23-oxa en la serie de la vitamina d, procedimiento para su preparacion, preparados farmaceuticos que contienen estos derivados asi como su utilizacion como medicamentos. - Google Patents
Derivados de 23-oxa en la serie de la vitamina d, procedimiento para su preparacion, preparados farmaceuticos que contienen estos derivados asi como su utilizacion como medicamentos.Info
- Publication number
- ES2089497T3 ES2089497T3 ES92903336T ES92903336T ES2089497T3 ES 2089497 T3 ES2089497 T3 ES 2089497T3 ES 92903336 T ES92903336 T ES 92903336T ES 92903336 T ES92903336 T ES 92903336T ES 2089497 T3 ES2089497 T3 ES 2089497T3
- Authority
- ES
- Spain
- Prior art keywords
- derivatives
- pct
- oxa
- vitamin
- series
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE DESCRIBEN DERIVADOS 23 UNO DE OTRO SIGNIFICAN UN ATOMO DE HIDROGENO O UN GRUPO ACIL CON 1 HASTA 9 ATOMOS DE CARBONO, R3 SIGNIFICA UN ATOMO DE HIDROGENO O UN GRUPO ALQUIL LINEAL O RAMIFICADO CON 1 HASTA 4 ATOMOS DE CARBONO Y X ES UN RESTO ALQUILENO GRUPO PROPIL, ASI COMO UN PROCESO PARA SU ELABORACION. LOS COMPUESTOS POSEEN EFECTO INHIBIDOR DE PROLIFERACION Y DIFERENCIADOR DE CELULAS Y SON APROPIADOS PARA LA FABRICACION DE MEDICAMENTOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4101953A DE4101953A1 (de) | 1991-01-19 | 1991-01-19 | 23-oxa-derivate in der vitamin-d-reihe, verfahren zu ihrer herstellung diese derivate enthaltende pharmazeutische praeparate sowie deren verwendung als arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2089497T3 true ES2089497T3 (es) | 1996-10-01 |
Family
ID=6423566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92903336T Expired - Lifetime ES2089497T3 (es) | 1991-01-19 | 1992-01-20 | Derivados de 23-oxa en la serie de la vitamina d, procedimiento para su preparacion, preparados farmaceuticos que contienen estos derivados asi como su utilizacion como medicamentos. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5411949A (es) |
EP (1) | EP0639179B1 (es) |
JP (1) | JP3207423B2 (es) |
AT (1) | ATE138647T1 (es) |
DE (2) | DE4101953A1 (es) |
DK (1) | DK0639179T3 (es) |
ES (1) | ES2089497T3 (es) |
GR (1) | GR3020083T3 (es) |
IE (1) | IE74251B1 (es) |
PT (1) | PT100035B (es) |
WO (1) | WO1992012963A1 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994008958A1 (en) * | 1992-10-16 | 1994-04-28 | Chugai Seiyaku Kabushiki Kaisha | Vitamin d derivative and process for producing the same |
TW267161B (es) * | 1992-11-20 | 1996-01-01 | Hoffmann La Roche | |
US6407082B1 (en) * | 1996-09-13 | 2002-06-18 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a vitamin D compound |
US20040167106A1 (en) * | 1993-06-04 | 2004-08-26 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of a Vitamin D compound |
AU1429397A (en) * | 1995-12-29 | 1997-07-28 | A And D Assay, Incorporated | Labeled vitamin d compounds and the use thereof |
US6034074A (en) * | 1996-09-13 | 2000-03-07 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a Vitamin D compound |
US6765002B2 (en) | 2000-03-21 | 2004-07-20 | Gustavo Rodriguez | Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium |
US6028064A (en) | 1996-09-13 | 2000-02-22 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of progestin products |
US6511970B1 (en) | 1996-09-13 | 2003-01-28 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
US6087350A (en) * | 1997-08-29 | 2000-07-11 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Use of pretreatment chemicals to enhance efficacy of cytotoxic agents |
US6521608B1 (en) | 1998-03-27 | 2003-02-18 | Oregon Health & Science University | Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders |
US6537980B1 (en) | 1999-04-23 | 2003-03-25 | Leo Pharmaceutical Products Ltd. | Vitamin D analogues and their pharmaceutical use |
US20010044431A1 (en) * | 2000-03-21 | 2001-11-22 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
US8106035B2 (en) * | 2002-12-18 | 2012-01-31 | Cytochroma Inc. | 25-SO2-substituted analogs of 1μ,25-dihydroxyvitamin D3 |
EP1879595B1 (en) * | 2005-05-10 | 2014-09-24 | Dermipsor Ltd | Compositions and methods for treating hyperproliferative epidermal diseases |
US20080051375A1 (en) * | 2006-08-25 | 2008-02-28 | Auerbach Alan H | Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same |
CN101528309A (zh) | 2006-08-25 | 2009-09-09 | 库伽尔生物科技公司 | 包括给予维生素d化合物和另外的治疗剂的治疗癌症的方法 |
US20080051380A1 (en) * | 2006-08-25 | 2008-02-28 | Auerbach Alan H | Methods and compositions for treating cancer |
WO2009009132A1 (en) * | 2007-07-12 | 2009-01-15 | Cougar Biotechnology, Inc. | Use of 17alpha-hydroxylase/c17, 20-lyase inhibitors for the treatment of cancer |
EA201691980A1 (ru) * | 2009-01-27 | 2017-07-31 | БЕРГ ЭлЭлСи | Способы уменьшения побочных эффектов, связанных с химиотерапией |
SG178382A1 (en) | 2009-08-14 | 2012-04-27 | Berg Biosystems Llc | Vitamin d3 and analogs thereof for treating alopecia |
FI124171B (en) | 2012-05-29 | 2014-04-15 | Matti Mällinen | Biofilter |
US20190183908A1 (en) | 2016-05-13 | 2019-06-20 | Case Western Reserve University | Autophagy activators for treating or preventing skin injury |
MA45780A (fr) | 2016-07-29 | 2019-06-05 | Janssen Pharmaceutica Nv | Méthodes de traitement du cancer de la prostate |
US11903952B2 (en) | 2020-05-27 | 2024-02-20 | Northwestern University | Vitamin D as an immune modulator to prevent immune-related complication from COVID-19 infection |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3276167D1 (en) * | 1981-11-02 | 1987-06-04 | Res Inst Medicine Chem | Intermediates in the synthesis of vitamin d derivatives |
EP0184112B1 (en) * | 1984-11-27 | 1990-05-09 | Chugai Seiyaku Kabushiki Kaisha | Novel vitamin d derivatives and process for producing the same |
GB8904153D0 (en) * | 1989-02-23 | 1989-04-05 | Leo Pharm Prod Ltd | Chemical compounds |
GB9007236D0 (en) * | 1990-03-30 | 1990-05-30 | Leo Pharm Prod Ltd | Chemical compounds |
-
1991
- 1991-01-19 DE DE4101953A patent/DE4101953A1/de not_active Ceased
-
1992
- 1992-01-17 PT PT100035A patent/PT100035B/pt not_active IP Right Cessation
- 1992-01-20 ES ES92903336T patent/ES2089497T3/es not_active Expired - Lifetime
- 1992-01-20 IE IE920156A patent/IE74251B1/en not_active IP Right Cessation
- 1992-01-20 EP EP92903336A patent/EP0639179B1/de not_active Expired - Lifetime
- 1992-01-20 US US08/090,201 patent/US5411949A/en not_active Expired - Fee Related
- 1992-01-20 AT AT92903336T patent/ATE138647T1/de not_active IP Right Cessation
- 1992-01-20 WO PCT/EP1992/000123 patent/WO1992012963A1/de active IP Right Grant
- 1992-01-20 DE DE59206439T patent/DE59206439D1/de not_active Expired - Lifetime
- 1992-01-20 DK DK92903336.3T patent/DK0639179T3/da active
- 1992-01-20 JP JP50348292A patent/JP3207423B2/ja not_active Expired - Fee Related
-
1996
- 1996-05-30 GR GR960401330T patent/GR3020083T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT100035B (pt) | 1999-08-31 |
DK0639179T3 (da) | 1996-10-14 |
PT100035A (pt) | 1993-05-31 |
GR3020083T3 (en) | 1996-08-31 |
IE74251B1 (en) | 1997-07-16 |
IE920156A1 (en) | 1992-07-29 |
DE4101953A1 (de) | 1992-07-23 |
EP0639179A1 (de) | 1995-02-22 |
US5411949A (en) | 1995-05-02 |
EP0639179B1 (de) | 1996-05-29 |
ATE138647T1 (de) | 1996-06-15 |
JPH06506915A (ja) | 1994-08-04 |
DE59206439D1 (de) | 1996-07-04 |
JP3207423B2 (ja) | 2001-09-10 |
WO1992012963A1 (de) | 1992-08-06 |
EP0639179A4 (de) | 1993-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2089497T3 (es) | Derivados de 23-oxa en la serie de la vitamina d, procedimiento para su preparacion, preparados farmaceuticos que contienen estos derivados asi como su utilizacion como medicamentos. | |
ES2075202T3 (es) | Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen. | |
AR037517A1 (es) | Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria | |
ES2095432T3 (es) | Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
MX9303799A (es) | Derivados de la serie de vitamina d con modificaciones en la posicon 20, procedimiento para su preparacion, productos intermedios para este procedimiento, preparados farmaceuticos que contienen estos derivados asi como su utilizacion para la prod. | |
AR029383A1 (es) | Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes | |
ES2052166T3 (es) | Derivados de 24-homo-vitamina-d, procedimiento para su preparacion, preparados farmaceuticos que contienen estos derivados asi como su utilizacion como medicamentos. | |
ES2102475T3 (es) | Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
IL69751A0 (en) | Diazabicyclo-(3.3.1)-nonanes,their preparation and pharmaceutical compositions containing them | |
MX9204637A (es) | Nuevos derivados de pirazina y procedimiento para su preparacion. | |
SE8303013L (sv) | B-gamma-dihydropolyprenylalkoholderivat och farmaceutisk komposition innehallande en polyprenylforening | |
DK0649405T3 (da) | 22-en-25-oxa-derivater i D-vitaminserien, fremgangsmåde til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt anvendelse af sådanne præparater som lægemidler. | |
ES2088241T3 (es) | Nuevos esteroides que comprenden en posicion 17 un radical metileno-lactona, su procedimiento y productos intermedios de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen. | |
MX9301404A (es) | Derivados de 2-oxoquinolina, procedimiento para su preparacion, preparado farmaceutico que los contiene y procedimiento para la obtencion de tal preparado farmaceutico. | |
ES2091126T3 (es) | Nuevos compuestos biciclicos de pirimidina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
ES2057802T3 (es) | Nuevos derivados de 3-amino-cromano, procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
ES8707111A1 (es) | Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas. | |
ES2138226T3 (es) | Derivados del acido imidazo(1,2-a)indeno(1,2-e)pirazina-2-carboxilico, su preparacion y los medicamentos que les contienen. | |
FI960465A (fi) | 15,15-dialkyylisubstituoituja estradiolin johdannaisia | |
MX9303392A (es) | Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion. | |
IT1215587B (it) | Derivati della 1-benzoil2-oxo 5-alcossi pirrolidina, loro procedimento di preparazione e loro impiego come sostanza medicinale. | |
ES2158309T3 (es) | Fenilamidinas sustituidas, medicamentos que contienen a estos compuestos y procedimiento para su preparacion. | |
HUT42099A (en) | Process for preparing 2,3-diamino-2,3-dideoxy-hexose derivatives and pharmaceutical compositions containing thereof as active substances | |
DK0865422T3 (da) | Anvendelse af aminoalkoholderivater som lægemidler, hidtil ukendte derivater og fremgangsmåde til fremstilling deraf | |
ES2085922T3 (es) | 3-tia- o 3-oxa-alquil-flavonas sustituidas, procedimiento para su preparacion, empleo de las mismas, medicamentos a base de estos compuestos, asi como productos intermedios. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 639179 Country of ref document: ES |
|
FG2A | Definitive protection |
Ref document number: 639179 Country of ref document: ES |